A Phase 3 Efficacy Study Of Dimebon In Patients With Moderate To Severe Alzheimer's Disease

This study has been terminated.

( See termination reason in detailed description. )

Study NCT00912288 Information provided by Pfizer

First Received: June 1, 2009 Last Updated: September 8, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	August 2010
Primary Completion Date:	August 2010 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: September 8, 2011